GleamWall
中文EN

AMGN AMGEN INC

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 318154 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.2%
TTM net income YoY34.1%
TTM EPS YoY33.4%
Revenue 3-yr CAGR13.2%
Net income 3-yr CAGR7.5%

Margins

Gross margin70.9%
Operating margin32.4%
Net margin24.1%
FCF margin24.6%
EBITDA margin39.4%

Returns

ROE78.4%
ROA10.1%
ROIC (approx.)19.5%
Asset turnover0.42x

Leverage & solvency

Liabilities / assets85.1%
Debt / equity3.76x
Current ratio1.48x
Interest coverage4.78x

Cash quality & payout

Operating cash flow / net income1.28x
Accruals ratio-2.8%
Payout ratio57.1%
Capex / revenue6.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$36.75B$33.42B
Cost of revenue$12.04B$12.86B
Gross profit$24.71B$20.57B
R&D expense$7.27B$5.96B
SG&A expense$7.05B$7.10B
Operating income$9.08B$7.26B
Interest expense$2.75B$3.15B
Pretax income$8.98B$4.61B
Income tax$1.26B$519.00M
Net income$7.71B$4.09B
EBITDA$14.25B$12.85B
EPS (basic)14.337.62
EPS (diluted)14.237.56
Dividends declared per share9.669.13
Weighted avg. shares (diluted)542.00M541.00M
Balance sheet
Cash & equivalents$9.13B$11.97B
Receivables$9.57B$6.78B
Inventory$6.22B$7.00B
Current assets$29.06B$29.03B
PP&E, net$7.91B$6.54B
Goodwill$18.68B$18.64B
Intangibles$22.28B$27.70B
Total assets$90.59B$91.84B
Current liabilities$25.49B$23.10B
Short-term debt$4.60B$3.55B
Long-term debt$50.01B$56.55B
Total debt$54.60B$60.10B
Total liabilities$81.93B$85.96B
Shareholders' equity$8.66B$5.88B
Net debt$45.48B$48.13B
Shares outstanding538.80M536.90M
Cash flow statement
Operating cash flow$9.96B$11.49B
Capital expenditure$1.86B$1.10B
Free cash flow$8.10B$10.39B
Investing cash flow-$1.94B-$1.05B
Financing cash flow-$10.86B-$9.41B
Depreciation & amortization$5.17B$5.59B
Stock-based compensation$494.00M$530.00M
Dividends paid$5.12B$4.83B
Share buybacks$0$200.00M

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.